Literature DB >> 31351415

The Why, Where, Who, How, and What of the vesicular delivery systems.

Bhupinder Kapoor1, Reena Gupta1, Monica Gulati2, Sachin Kumar Singh1, Rubiya Khursheed1, Mukta Gupta1.   

Abstract

Though vesicular delivery systems have been widely explored and reviewed, no comprehensive review exists that covers their development from the inception of the concept to its culmination in the form of regulated marketed formulations. With the advancement of scientific research in the field of nanomedicine, certain category of vesicular delivery systems have successfully reached the global market. Despite extensive research and highly encouraging results in a plethora of pathological conditions in the preclinical studies, translation of these nanomedicines from laboratory to market has been very limited. Aim of this review is to describe comprehensively the various colloidal delivery systems, focusing mainly on their conventional and advanced methods of preparation, different characterization techniques and main success stories of their journey from bench to bedside of the patient. The review also touches the finer nuances of the use of modern formulation approach of DoE (Design of Experiments) in their formulation and the status of regulatory guidelines for the approval of these nanomedicines.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Liposomes; Marketed vesicular formulations; Nanomedicine; Niosomes; Vesicular delivery

Year:  2019        PMID: 31351415     DOI: 10.1016/j.cis.2019.07.006

Source DB:  PubMed          Journal:  Adv Colloid Interface Sci        ISSN: 0001-8686            Impact factor:   12.984


  9 in total

Review 1.  Trends and challenges in phytotherapy and phytocosmetics for skin aging.

Authors:  Idris Adewale Ahmed; Maryam Abimbola Mikail; Nor Hisam Zamakshshari; Mohd Rais Mustafa; Najihah Mohd Hashim; Rozana Othman
Journal:  Saudi J Biol Sci       Date:  2022-06-23       Impact factor: 4.052

Review 2.  Oral Nano Drug Delivery Systems for the Treatment of Type 2 Diabetes Mellitus: An Available Administration Strategy for Antidiabetic Phytocompounds.

Authors:  Xin Nie; Zhejie Chen; Lan Pang; Lin Wang; Huajuan Jiang; Yi Chen; Zhen Zhang; Chaomei Fu; Bo Ren; Jinming Zhang
Journal:  Int J Nanomedicine       Date:  2020-12-16

3.  Development and characterization of a nano-drug delivery system containing vasaka phospholipid complex to improve bioavailability using quality by design approach.

Authors:  Sundaresan Nandhini; Kaliappan Ilango
Journal:  Res Pharm Sci       Date:  2020-12-30

Review 4.  Mechanistic Understanding From Molecular Dynamics Simulation in Pharmaceutical Research 1: Drug Delivery.

Authors:  Alex Bunker; Tomasz Róg
Journal:  Front Mol Biosci       Date:  2020-11-25

Review 5.  Self-Assembling Drug Formulations with Tunable Permeability and Biodegradability.

Authors:  Gulnara Gaynanova; Leysan Vasileva; Ruslan Kashapov; Darya Kuznetsova; Rushana Kushnazarova; Anna Tyryshkina; Elmira Vasilieva; Konstantin Petrov; Lucia Zakharova; Oleg Sinyashin
Journal:  Molecules       Date:  2021-11-10       Impact factor: 4.411

Review 6.  The Optimized Delivery of Triterpenes by Liposomal Nanoformulations: Overcoming the Challenges.

Authors:  Andreea Milan; Alexandra Mioc; Alexandra Prodea; Marius Mioc; Roxana Buzatu; Roxana Ghiulai; Roxana Racoviceanu; Florina Caruntu; Codruţa Şoica
Journal:  Int J Mol Sci       Date:  2022-01-20       Impact factor: 5.923

7.  Critical Analysis and Quality Assessment of Nanomedicines and Nanocarriers in Clinical Trials: Three Years of Activity at the Clinical Trials Office.

Authors:  Diego Alejandro Dri; Elisa Gaucci; Ilaria Torrieri; Maria Carafa; Carlotta Marianecci; Donatella Gramaglia
Journal:  Pharmaceutics       Date:  2022-07-09       Impact factor: 6.525

8.  Mechanistic Insight into How PEGylation Reduces the Efficacy of pH-Sensitive Liposomes from Molecular Dynamics Simulations.

Authors:  Mohammad Mahmoudzadeh; Aniket Magarkar; Artturi Koivuniemi; Tomasz Róg; Alex Bunker
Journal:  Mol Pharm       Date:  2021-06-06       Impact factor: 4.939

9.  Surfactants, Nanomedicines and Nanocarriers: A Critical Evaluation on Clinical Trials.

Authors:  Diego Alejandro Dri; Carlotta Marianecci; Maria Carafa; Elisa Gaucci; Donatella Gramaglia
Journal:  Pharmaceutics       Date:  2021-03-13       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.